Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.

Firefly Aerospace has filed paperwork to go public, part of a trend of space companies taking traditional approaches to public markets.

Varda Space Industries has secured $187 million from investors, including Natural Capital and Shrug Capital, to advance its ...

Varda Space Industries secures $187 million in funding to advance its groundbreaking technology for drug manufacturing in ...

Varda Space Industries, a company developing spacecraft for microgravity life sciences and hypersonics research, has raised ...

Varda Space Industries has raised $187 million to accelerate drug development in space using microgravity technology.

Varda Space Industries announced its Series C fundraiser for medicine creation in space has reached $187 million. This now ...

In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...

The funds will be used to expand Varda's pharmaceutical manufacturing capabilities in microgravity and increase the cadence of orbital missions.

Varda Space Industries said on Thursday it has raised $187 million in a funding round led by venture capital firms Natural Capital and Shrug Capital to boost the technology for robotic drug ...

Will Bruey, Varda CEO, and Delian Asparouhov, co-founder, discuss their latest series C funding as they look to expand their ...

Pharmaceutical scientists come up against a hard limitation here on Earth: gravity. Varda Space wants to change that. The ...